{"result": "(\"entity\"<|>NEYRINCK<|>PERSON<|>Neyrinck is a researcher who studied the effects of broad-spectrum antibiotics on the microbiota of obese rodents.)\n##\n(\"entity\"<|>DEKZENNE<|>PERSON<|>Dekzenne is a researcher who collaborated with Neyrinck on studies regarding antibiotics and microbiota.)\n##\n(\"entity\"<|>AKKERMANSIA MUCINIPHILA<|>ORGANIZATION<|>Akkermansia muciniphila is a beneficial bacterium that can increase in abundance due to broad-spectrum antibiotic treatment, potentially reducing diabetes incidence.)\n##\n(\"entity\"<|>VANCOMICINA<|>ORGANIZATION<|>Vancomicina is a broad-spectrum antibiotic that has been shown to affect the microbiota positively in certain studies.)\n##\n(\"entity\"<|>MEMBREZ<|>PERSON<|>Membrez is a researcher who studied the effects of antibiotics on genetically obese rodents with insulin resistance.)\n##\n(\"entity\"<|>CANI<|>PERSON<|>Cani is a researcher who supports the idea that broad-spectrum antibiotic therapy significantly reduces plasma levels of lipopolysaccharides in animal models.)\n##\n(\"entity\"<|>H. PYLORI<|>ORGANIZATION<|>H. pylori is a bacterium that can infect humans and has been mentioned in studies related to antibiotic exposure and weight gain.)\n##\n(\"entity\"<|>FIBROSIS QUÍSTICA<|>ORGANIZATION<|>Fibrosis quística is a genetic disorder that has been associated with antibiotic exposure and weight gain in studies.)\n##\n(\"entity\"<|>OBESIDAD<|>EVENT<|>Obesity is a growing public health issue linked to antibiotic use and microbiota alterations.)\n##\n(\"entity\"<|>ANTIBIOTIC THERAPY<|>EVENT<|>Antibiotic therapy refers to the use of antibiotics to treat infections, which has been studied for its effects on microbiota and weight gain.)\n##\n(\"entity\"<|>METABOLIC DISEASES<|>EVENT<|>Metabolic diseases are conditions that have seen a significant increase in prevalence, potentially linked to antibiotic use and microbiota changes.)\n##\n(\"relationship\"<|>NEYRINCK<|>DEKZENNE<|>Neyrinck and Dekzenne collaborated on research regarding the effects of antibiotics on microbiota in obese rodents<|>7)\n##\n(\"relationship\"<|>NEYRINCK<|>AKKERMANSIA MUCINIPHILA<|>Neyrinck's research indicates that broad-spectrum antibiotics can increase the abundance of Akkermansia muciniphila<|>6)\n##\n(\"relationship\"<|>VANCOMICINA<|>AKKERMANSIA MUCINIPHILA<|>Vancomicina treatment has been shown to increase Akkermansia muciniphila levels in certain studies<|>6)\n##\n(\"relationship\"<|>MEMBREZ<|>H. PYLORI<|>Membrez's studies involve the effects of antibiotics on conditions related to H. pylori infection<|>5)\n##\n(\"relationship\"<|>CANI<|>METABOLIC DISEASES<|>Cani's research supports the link between antibiotic therapy and metabolic diseases<|>6)\n##\n(\"relationship\"<|>MEMBREZ<|>OBESIDAD<|>Membrez's studies indicate that antibiotic treatment can improve glucose tolerance and weight in obese rodents<|>7)\n##\n(\"relationship\"<|>H. PYLORI<|>OBESIDAD<|>H. pylori infection has been linked to weight gain and metabolic issues in various studies<|>5)\n##\n(\"relationship\"<|>FIBROSIS QUÍSTICA<|>OBESIDAD<|>Fibrosis quística has been associated with weight gain in subjects exposed to antibiotics<|>5)\n##\n(\"relationship\"<|>ANTIBIOTIC THERAPY<|>METABOLIC DISEASES<|>Antibiotic therapy has been linked to the increasing prevalence of metabolic diseases<|>6)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: aciones importantes en la microbiota\nintestinal tras su uso: disminución de la diversidad filo-\ngenética y cambios en las proporciones de las diferen-\ntes familias, lo que puede alterar el desarrollo del siste-\nma inmune y predisponer al anfitrión a desarrollar\ninfecciones bacterianas o virales, alergias, etc.42. Los\nantibióticos tienen un profundo efecto sobre la micro-\nbiota, y su uso excesivo está unido a un aumento de\npatógenos resistentes a los antibióticos. Ahora hay\npruebas convincentes de que existen modificaciones\nimportantes en la microbiota después de un tratamien-\nto con antibióticos43-45. Aunque el particular taxón\nafectado varía entre individuos, algunos taxones no se\nrecuperan incluso después de meses de tratamiento, y\nen general, hay una disminución a largo plazo en la\nbiodiversidad de las bacterias tras su uso.\n\nMuchos estudios han sido publicados al respecto;\nasí, Neyrinck y Dekzenne46, observaron tras la adminis-\ntración de un antibiótico de amplio espectro en roedo-\nres obesos una mejora en las alteraciones metabólicas\ny cambios en filos como Firmicutes, Bacteroidetes y\nProteobacteria. Además, varios experimentos47 han de-\nmostrado que el uso de tratamientos antibióticos de\namplio espectro como la vancomicina puede incre-\nmentar la abundancia de Akkermansia muciniphila en\nroedores, reduciendo la incidencia de diabetes. Asimis-\nmo, Cani et al, apoyan que la antibioterapia de amplio\nespectro reduce significativamente los niveles plasmáti-\ncos de lipopolisacáridos (LPS) en modelos animales48.\nEn sus estudios, Membrez et al49, objetivaron cómo\nroedores genéticamente obesos que presentaban resis-\ntencia a la insulina y que estaban sometidos a una die-\nta alta en grasas mejoraron la tolerancia a la glucosa y\nel peso al someterse a tratamiento antibiótico. El uso\nde antibioterapia redujo el grado de inflamación del\ntejido adiposo, así como el estrés oxidativo y la infiltra-\nción de macrófagos del mismo.\n\nDe otro lado, algunos estudios han asociado la expo-\nsición a antibióticos con aumentos de la masa corporal\nen diferentes circunstancias, como son los primeros\nmeses de la vida, durante la infancia, en sujetos desnu-\ntridos, animales, infectados por H. pylori, enfermos\ncon fibrosis quística, etc. sin poder discernir si este\naumento de peso es debido a los efectos beneficiosos\ndel tratamiento antibiótico en la prevención o trata-\nmiento de infecciones bacterianas o a través de sus\n---\n174      BLOQUE: ALTERACIONES DE LA ENERGÍA\n\nefectos sobre la microbiota, siendo plausible que estén presentes una mezcla de estos dos mecanismos en muchos de los escenarios descritos50-54.\n\nEstudios epidemiológicos han apoyado el aumento del riesgo de sobrepeso en la infancia tardía con la exposición a terapia antibiótica en la primera infancia55. Incluso han relacionado el progresivo aumento de obesidad poblacional con el uso creciente de antibióticos56, 57. Durante décadas, dosis subterapéuticas de antibióticos se han utilizado para promover el crecimiento de animales de granja, con incremento de masa grasa, relacionándose incluso el uso creciente de antibióticos con el aumento de la obesidad58, 59. En contraste con estas observaciones, la exposición a antibióticos en los primeros años de vida en niños de madres con sobrepeso se ha asociado con un menor riesgo de sobrepeso en la infancia60. En conjunto, estos estudios pueden sugerir que la exposición a antibióticos en etapas tempranas de la vida puede perturbar la microbiota intestinal sana, pero, por otro lado, también tiene el potencial de modificar una microbiota perturbada hacia un estado más saludable61.\n\n## 3. Microbiota y enfermedades metabólicas\n\n### 3.1. Los factores genéticos y ambientales no son suficientes para explicar la creciente aparición de enfermedades metabólicas\n\nEn las últimas décadas estamos viviendo un incremento espectacular de la prevalencia de enfermedades metabólicas en los países desarrollados o en vías de desarrollo y el vertiginoso incremento de la obesidad está a la cabeza. Un análisis reciente publicado sobre tendencias del IMC en 200 países62 estima que la prevalencia mundial de obesidad ha pasado de 105 millones de personas a 641 millones en solo cuatro décadas, y de mantenerse esta tendencia, para el año 2025 la quinta parte de la población del planeta será obesa, alcanzando el 18% en los varones\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}